The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
Digital physical activity intervention via the Kidney BEAM platform in patients with polycystic kidney disease
ERA Journal Club
Digital physical activity intervention via the Kidney BEAM platform in patients with polycystic kidney disease: a randomised controlled trial
Access the article here
Speaker
Sharlene Greenwood, United Kingdom
Panellists
Naomi Clyne, Sweden
Emilie Cornec-Le Gall, France
Moderators
Andreas Kronbichler, Austria
Amaryllis Van Craenenbroeck, Belgium
Thursday, March 27, 2025, 5:00 PM (CET)